Emphysematous changes and lower levels of plasma irisin are associated with bronchiolitis obliterans syndrome after bilateral living-donor lobar lung transplantation

• Published in: Surgery today (Tokyo, Japan) Vol. 52; no. 2; pp. 294 - 305
• Main Authors: Shiotani, Toshio, Sugimoto, Seiichiro, Yamamoto, Haruchika, Miyoshi, Kentaroh, Otani, Shinji, Suzawa, Ken, Yamamoto, Hiromasa, Okazaki, Mikio, Yamane, Masaomi, Toyooka, Shinichi
• Format: Journal Article
• Language: English
• Published: Singapore Springer Singapore 01.02.2022
• Subjects: Adult; Biomarkers - blood; Bronchiolitis Obliterans - diagnosis; Bronchiolitis Obliterans - etiology; Emphysema - blood; Emphysema - diagnosis; Emphysema - etiology; Emphysema - pathology; Female; Fibronectins - blood; Humans; Living Donors; Lung Transplantation - adverse effects; Male; Medicine; Medicine & Public Health; Middle Aged; Original Article; Patient Acuity; Postoperative Complications - diagnosis; Postoperative Complications - etiology; Surgery; Surgical Oncology; Syndrome; Young Adult; Irisin; Chronic lung allograft dysfunction; Living-donor; Emphysema; Lung transplantation
• ISSN: 0941-1291; 1436-2813; 1436-2813
• DOI: 10.1007/s00595-021-02339-w

Purpose Decreased irisin levels may be associated with the development of emphysema. Similarly, emphysematous changes may develop in patients with chronic lung allograft dysfunction (CLAD) after living-donor lobar lung transplantation (LDLLT). We investigated the severity of emphysematous changes and the relationship between irisin levels and CLAD after bilateral LDLLT and cadaveric lung transplantation (CLT). Methods The subjects of this retrospective study were 59 recipients of bilateral LDLLT ( n  = 31) or CLT ( n  = 28), divided into a non-CLAD group ( n  = 41), a LDLLT-CLAD group ( n  = 11), and a CLT-CLAD group ( n  = 7). We compared the severity of emphysematous changes, the skeletal muscle mass, and the plasma irisin levels among the groups. Results The emphysematous changes were significantly more severe in the LDLLT-CLAD and CLT-CLAD groups ( p  = 0.046 and 0.036), especially in patients with bronchiolitis obliterans syndrome (BOS), than in the non-CLAD group. Although the skeletal muscle mass was similar in all the groups, the plasma irisin levels were significantly lower in the LDLLT-CLAD group ( p  = 0.022), especially in the patients with BOS after LDLLT, than in the non-CLAD group. Conclusion Emphysematous changes and lower levels of plasma irisin were associated with CLAD, especially in patients with BOS, after bilateral LDLLT.